查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1974212

輸液幫浦及配件市場：按產品、操作方式、應用和最終用戶分類 - 2026-2032年全球預測

Infusion Pumps & Accessories Market by Product, Operation, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，輸液幫浦及配件市場價值將達到 192 億美元，到 2026 年將成長至 206.8 億美元，到 2032 年將達到 332.1 億美元，複合年成長率為 8.14%。

主要市場統計數據
基準年 2025 192億美元
預計年份：2026年 206.8億美元
預測年份 2032 332.1億美元
複合年成長率 (%) 8.14%

輸液幫浦及其配件在臨床安全、互聯互通和居家照護轉型中佔據核心地位，被認為是影響醫療設備。

輸液幫浦及配件產業正處於臨床需求、技術創新和不斷發展的醫療服務模式的交匯點。隨著在醫院、診所和家庭中精準輸注治療變得日益重要，兼具可靠性、連接性和以患者為中心的設計理念的設備已從輔助組件轉變為醫療服務流程的核心組成部分。本文將此類別置於更廣泛的醫療保健需求框架下進行探討：提高安全性、加強門診和居家護理，以及支援數據驅動的臨床決策。

簡明扼要地整合了關鍵的變革性轉變，這些轉變重新定義了整個輸液泵生態系統中的產品設計、護理服務環境和監管要求。

由於三大因素的共同作用，輸液幫浦及相關設備的市場格局正在改變：技術成熟、醫療服務分散化以及監管和網路安全力度加大。醫療設備製造商正在整合先進的感測器、更智慧的韌體和無線連接功能，使輸液泵能夠提供更豐富的遙測數據、實現遠端滴定並與臨床決策支援系統整合。因此，軟體更新路徑、互通性認證和以使用者為中心的設計在醫療設備的整個生命週期中都成為優先事項，旨在減輕醫護人員的負擔並最大限度地減少治療錯誤。

對 2025 年美國實施的關稅調整對供應鏈、採購和製造選擇的累積營運和策略影響進行重點分析。

2025 年美國關稅環境為製造商、供應商和醫療保健機構帶來了新的營運挑戰，影響採購、供應商選擇和整體生產策略。關稅調整提高了總到岸成本的透明度，迫使企業重新評估其供應商佈局和原料投入。擁有全球供應鏈的製造商正透過多元化零件來源、盡可能增加在地採購以及與值得信賴的供應商簽訂長期合約來降低波動風險。這種調整需要對替代供應商進行認證、進行額外的品質審核，並分配資金以確保緊急儲備，從而維持生產的連續性。

將產品類型、操作等級、臨床應用和最終用戶需求與不斷變化的商業性和臨床重點聯繫起來的詳細細分分析。

細分市場層面的趨勢揭示了每個產品類型、操作模式、臨床應用和終端用戶環境所面臨的微妙機會和營運挑戰。按產品分類，市場可分為配件和耗材以及輸液幫浦。在輸液幫浦領域，攜帶式輸液幫浦、腸道餵食幫浦、植入式輸液幫浦、胰島素輸液幫浦、病人自控鎮痛幫浦、注射器式輸液幫浦和容積式輸液幫浦各自反映了不同的應用場景、生命週期預期和服務模式。攜帶式輸液幫浦和胰島素幫浦優先考慮便攜性、用藥依從性支援和電池管理，而植入式輸液幫浦和容積式輸液幫浦則優先考慮長期可靠性、精準給藥以及與手術或住院患者的整合。配件和耗材是持續收入的來源，需要強大的物流和無菌保證。

關鍵區域洞察顯示醫療保健系統、法規環境和醫療保健服務模式的差異如何影響設備部署、供應策略和商業性方法。

區域趨勢表明，輸液幫浦及其配件的需求促進因素和普及管道因地區而異，反映了醫療基礎設施、管理體制和醫療服務模式的差異。在美洲，完善的報銷體系、對患者安全的高度重視以及互聯設備的快速普及正在影響著輸液泵及其配件的普及，因此供應商必須證明其產品能夠與電子健康記錄整合，並提供強大的服務網路。相較之下，在歐洲、中東和非洲，複雜的監管環境和各國不同的政策導致了需求的多樣性，這更有利於模組化產品平台和靈活的分銷策略。供應商通常會在認證、培訓和上市後監管方面採用區域性模式。

競爭動態的策略概述：強調產品差異化、服務品質、夥伴關係和證據生成是關鍵的成功因素。

輸液幫浦及配件產業的動態取決於技術差異化、服務能力、臨床證據產生和分銷網路拓展的綜合因素。擁有強大的產品系列組合、完善的售後支援和整合軟體平台的公司，在與醫療機構簽訂合約和支援長期治療方案方面更具優勢。醫療設備製造商與數位醫療公司之間的策略合作，正在將分析能力的提供範圍擴展到硬體、遠端監測和用藥依從性計劃之外，從而增加了轉型成本，並創造了新的、持續的收入來源。

為製造商、醫療保健提供者和採購團隊提供實用建議，將策略見解轉化為強大的產品策略、籌資策略和實證方法。

產業領導者應採取一系列切實可行的積極措施，將洞察轉化為可衡量的優勢。首先，互通性和網路安全應作為核心產品功能而非附加功能進行投資，以確保醫療設備能夠與醫院系統和遠端醫療平台安全地交換資料。其次，應擴展服務和支援範圍，包括遠端監控、預防性保養和臨床醫生培訓方案，以減少中斷並提高客戶終身價值。第三，應實現採購多元化，探索區域製造和夥伴關係模式，以降低關稅波動和運輸中斷帶來的風險，同時制定緊急庫存策略，以確保供應的連續性。

本執行摘要清楚地解釋了多方面的調查方法，該方法結合了初步訪談、文獻綜述和專家檢驗，以確保獲得紮實的實踐知識。

本執行摘要的研究結合了初步訪談、二手文獻分析、儀器文件審查​​以及跨領域專家檢驗，以確保全面平衡的觀點。初步資訊是透過對臨床醫生、生物醫學工程師、採購經理和行業高管的結構化訪談收集的，旨在了解實際應用中的挑戰和實際性能方面的考慮。二手分析包括監管申報文件、產品手冊和同行評審的臨床研究，以支持安全性、易用性和技術特性的論點。

一項權威的綜合分析證實了互通性、服務和彈性如何結合起來，從而在整個輸液泵生態系統中推動臨床價值和商業性成功。

總之，輸液幫浦及相關設備是現代醫療安全改進、居家醫療以及將治療服務與數位健康平台整合的關鍵所在。該領域正從獨立設備轉向涵蓋硬體、軟體和持續支援的服務型解決方案。這一趨勢有利於那些能夠提供無縫互通性、顯著臨床價值和可靠服務網路的公司。近期政策週期、關稅趨勢和供應鏈壓力進一步加劇了對多元化採購和增強營運韌性的需求。同時，不同地區在監管和醫療服務體系上的差異也要求企業採取適應性強的商業化策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 輸液幫浦及配件市場：依產品分類

  • 配件和耗材
  • 點滴幫浦
    • 家用輸液泵
    • 腸道餵食幫浦
    • 植入式輸液泵
    • 胰島素輸注泵
    • 患者自控鎮痛泵
    • 注射幫浦
    • 定量注射泵

第9章 輸液幫浦及配件市場：依操作方式分類

  • 電的
  • 機械驅動

第10章 輸液幫浦及配件市場：依應用領域分類

  • 糖尿病管理
  • 胃腸病學
  • 血液學
  • 神經病學
  • 腫瘤學
  • 疼痛管理

第11章 輸液幫浦及配件市場：依最終用戶分類

  • 學術和研究機構
  • 門診部
  • 居家醫療
  • 醫院和診所

第12章 輸液幫浦及配件市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 輸液幫浦及配件市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 輸液幫浦及配件市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國輸液幫浦及配件市場

第16章：中國輸液幫浦及配件市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Avanos Medical, Inc.
  • B. Braun SE
  • Baxter International, Inc.
  • Bayer AG
  • Becton, Dickinson, and Company
  • Boston Scientific Corporation
  • Cane SpA
  • Chemyx Inc.
  • Eitan Medical
  • Epic Medical Pty Ltd.
  • F. Hoffmann-La Roche AG
  • Fresenius SE & Co. KGaA
  • Freudenberg Group
  • FUJIFILM Corporation
  • ICU Medical, Inc.
  • IRadimed Corporation
  • Medtronic plc
  • Micrel Medical Devices SA
  • Moog Inc.
  • Narang Medical Limited
  • Nipro Corporation
  • Omnipod by Insulet Corporation
  • SAI Infusion Technologies
  • Shenzhen Hawk Medical Instrument Co., Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Teleflex Incorporated
  • TERUMO CORPORATION
  • Thermo Fisher Scientific Inc.
  • Ypsomed AG
Product Code: MRR-3B3453376B7D

The Infusion Pumps & Accessories Market was valued at USD 19.20 billion in 2025 and is projected to grow to USD 20.68 billion in 2026, with a CAGR of 8.14%, reaching USD 33.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 19.20 billion
Estimated Year [2026] USD 20.68 billion
Forecast Year [2032] USD 33.21 billion
CAGR (%) 8.14%

An authoritative introduction positioning infusion pumps and accessories at the center of clinical safety, connectivity, and home-based care transformations shaping device adoption

The infusion pump and accessories domain is at the intersection of clinical need, technological innovation, and shifting care delivery models. As hospitals, clinics, and homes increasingly demand precise delivery of therapies, devices that combine reliability with connectivity and patient-centric design have moved from adjuncts to central components of care pathways. This introduction situates the category within broader healthcare imperatives: improving safety, enabling ambulatory and home-based treatments, and supporting data-driven clinical decisions.

Over the past several years, incremental improvements in hardware have been complemented by leaps in software and connectivity. Consequently, infusion systems are no longer simply mechanical or electrical instruments; they are nodes in clinical information networks that must interoperate with electronic records and remote monitoring platforms. This shift has implications for procurement, clinical protocols, and vendor selection, as institutions weigh durability and warranty coverage alongside cybersecurity, interoperability, and usability. Furthermore, as patient populations age and chronic disease prevalence rises, the demand for devices that support long-term therapy adherence and minimize caregiver burden intensifies.

Finally, evolving regulatory expectations and reimbursement frameworks are reshaping how manufacturers design devices and how healthcare providers justify capital and operational expenditures. Together, these drivers create an environment where clinical efficacy, human factors, and systems integration define value. The remainder of this executive summary builds from this foundational context to examine transformative shifts, policy impacts, segmentation dynamics, regional differentiators, competitive positioning, recommended actions, and the methods used to assemble these insights.

A concise synthesis of the major transformative shifts redefining product design, care delivery settings, and regulatory expectations across infusion pump ecosystems

The landscape for infusion pumps and accessories is undergoing transformative shifts driven by three converging forces: technology maturation, care-delivery decentralization, and heightened regulatory and cybersecurity scrutiny. Device manufacturers are embedding advanced sensors, smarter firmware, and wireless connectivity so pumps can provide richer telemetry, enable remote titration, and integrate with clinical decision support. As a result, device lifecycles now prioritize software update pathways, interoperability certifications, and user-centered designs to minimize clinician burden and reduce therapy errors.

Simultaneously, patient care is moving beyond the hospital. Ambulatory infusion pumps and devices designed for home use are expanding the range of therapies delivered outside traditional settings. This movement alters value propositions; payers and providers increasingly prioritize total cost of care, patient satisfaction, and reduced readmissions. Therefore, vendors must demonstrate outcomes and support services that enable safe decentralization of complex therapies. Transitioning therapies out of inpatient wards also requires changes in training, remote monitoring, and supply chain reliability to ensure continuity of care.

Finally, regulatory landscapes and cybersecurity expectations have intensified. Stakeholders now demand robust risk management, timely vulnerability mitigation, and clear pathways for software maintenance and field updates. These pressures favor larger vendors with established quality systems, while also creating opportunities for niche players who can demonstrate strong clinical evidence and integration capabilities. In sum, the market is shifting from isolated device sales toward bundled offerings that combine hardware, software, and services to meet evolving clinical and operational needs.

A focused analysis of the cumulative operational and strategic effects that United States tariff adjustments in 2025 imposed on supply chains, procurement, and manufacturing choices

The 2025 United States tariff environment has introduced new operational considerations for manufacturers, suppliers, and healthcare providers that reverberate across procurement, sourcing, and manufacturing strategies. Tariff adjustments have increased the visibility of total landed cost and compelled organizations to reassess supplier footprints and material inputs. Manufacturers with globalized supply chains have responded by diversifying component sourcing, increasing localization where feasible, and negotiating longer-term agreements with trusted suppliers to mitigate volatility. This recalibration has required capital allocation toward alternative supplier qualification, additional quality audits, and contingency inventory to preserve production continuity.

For providers and group purchasing organizations, the tariff context elevates the importance of contract terms and supply chain transparency. Procurement teams are placing renewed emphasis on clauses that address cost pass-throughs, lead-time variability, and product substitution. At the same time, clinicians and biomedical teams are working with vendors to manage service continuity as manufacturers adapt component procurement or revise product configurations. These adjustments have sometimes led to temporary SKU rationalizations or delayed product launches as companies work through compliance and cost pressures.

Moreover, the tariff environment has accelerated conversations around onshoring and nearshoring for critical components and accessories. While reshoring can reduce exposure to cross-border tariffs and shipping disruptions, it also demands investment in domestic manufacturing capacity and the development of local supplier ecosystems. In parallel, manufacturers are investing in tooling and process improvements to offset higher input costs through efficiency gains. Ultimately, the cumulative impact of tariff changes in 2025 has been to intensify supply chain resilience planning, drive procurement and product strategy realignment, and prioritize transparency across the value chain so that healthcare organizations and manufacturers can jointly manage cost and continuity risks.

In-depth segmentation insights linking product categories, operational classes, clinical applications, and end-user requirements to evolving commercial and clinical priorities

Segment-level dynamics reveal nuanced opportunities and operational challenges across product categories, modes of operation, clinical applications, and end-user settings. Based on Product, the market is studied across Accessories & Consumables and Infusion Pumps; within Infusion Pumps, Ambulatory Infusion Pumps, Enteral Feeding Pumps, Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Syringe Infusion Pumps, and Volumetric Infusion Pumps reflect distinct clinical use cases, lifecycle expectations, and service models. Ambulatory and insulin pumps emphasize portability, adherence support, and battery management, whereas implantable and volumetric systems prioritize long-term reliability, precision dosing, and surgical or inpatient integration. Accessories and consumables drive recurring revenue streams and require robust logistics and sterilization assurances.

Based on Operation, the market is studied across Electrically Operated and Mechanically Operated devices, and each operational class carries different maintenance regimes, training requirements, and failure-mode profiles. Electrically operated systems increasingly include software-driven fail-safes and remote telemetry, which augment performance but also introduce cybersecurity and update management needs. Mechanically operated pumps, often valued for simplicity and reliability, remain relevant in constrained environments and as backup systems where electronic complexity is impractical.

Based on Application, the market is studied across Diabetes Management, Gastroenterology, Hematology, Neurology, Oncology, and Pain Management, each of which imposes unique dosing regimens, monitoring needs, and payer considerations. Diabetes management and oncology therapies, in particular, demand tight adherence and integration with patient monitoring to optimize outcomes. Finally, Based on End-User, the market is studied across Academic & Research Institutes, Ambulatory Care Settings, Home Care, and Hospitals & Clinics, with each end-user segment prioritizing different procurement cycles, service agreements, and training investments. Academic centers and hospitals focus on feature-rich, interoperable systems, while home care emphasizes ease of use and remote support.

Key regional insights demonstrating how differing healthcare systems, regulatory environments, and care delivery models shape device adoption, supply strategies, and commercial approaches

Regional patterns demonstrate that demand drivers and adoption pathways for infusion pumps and accessories vary markedly across geographies, reflecting differences in healthcare infrastructure, regulatory regimes, and care delivery models. In the Americas, adoption is shaped by sophisticated reimbursement frameworks, a strong emphasis on patient safety, and rapid uptake of connected devices, which together encourage vendors to demonstrate integration with electronic medical records and to provide robust service networks. By contrast, regulatory complexity and divergent national policies across Europe, Middle East & Africa create a patchwork of requirements that favor modular product platforms and flexible distribution strategies; vendors often deploy regionally tailored models for certification, training, and post-market surveillance.

Asia-Pacific exhibits a mix of rapid public and private investment in hospital modernization, expanding access to home-based care, and a broad spectrum of clinical practice patterns. These dynamics create both scale opportunities and the need for localized approaches to pricing and training. Across all regions, telehealth expansion and workforce constraints are convergent trends that shape product value propositions: devices that reduce clinician workload and enable remote management gain traction universally. In addition, regional supply chain considerations, currency movements, and local manufacturing incentives influence where companies invest in capacity and how they structure distribution agreements. Therefore, geographic strategy must balance global product consistency with local regulatory, clinical, and commercial adaptations.

A strategic overview of competitive dynamics emphasizing product differentiation, service excellence, partnerships, and evidence generation as key success factors

Competitive dynamics in the infusion pump and accessories space are defined by a blend of technological differentiation, service capabilities, clinical evidence generation, and distribution reach. Companies that combine robust product portfolios with strong post-sale support and integrated software platforms are better positioned to win institutional contracts and to support long-term therapy pathways. Strategic partnerships between device manufacturers and digital health firms are expanding offerings beyond hardware to include analytics, remote monitoring, and adherence programs, thereby creating higher switching costs and new avenues for recurring revenue.

At the same time, smaller and more specialized vendors are leveraging niche clinical expertise and agile development cycles to address unmet needs, such as compact ambulatory devices or accessories optimized for low-resource settings. These players can be attractive partners for larger firms seeking innovation without incurring the full R&D expense. Moreover, service differentiation-such as rapid field response, extended warranties, and clinician training-remains a critical competitive lever, particularly as institutions emphasize uptime and total cost of ownership.

Finally, intellectual property around infusion algorithms, safety interlocks, and interoperability standards contributes to competitive barriers. Companies that invest in clinical studies and real-world evidence can more credibly demonstrate outcomes and justify premium positioning. Given these dynamics, market participants need to balance product innovation with scalable service models and evidence generation to sustain growth and defend market positions.

Actionable recommendations for manufacturers, providers, and procurement teams that translate strategic insights into resilient product, sourcing, and evidence-driven approaches

Industry leaders should adopt a set of pragmatic, forward-looking actions to convert insights into measurable advantage. First, invest in interoperability and cybersecurity as core product features rather than add-ons, ensuring devices can securely exchange data with hospital systems and telehealth platforms. Second, expand service and support offerings to include remote monitoring, preventive maintenance, and clinician training bundles that reduce operational disruption and increase customer lifetime value. Third, diversify sourcing and consider regional manufacturing or partnership models to reduce exposure to tariff volatility and shipping disruptions, while simultaneously developing contingency inventory strategies to preserve continuity of supply.

In parallel, companies should accelerate evidence generation through post-market studies and real-world data initiatives that link device performance to clinical outcomes and cost metrics. This evidence supports procurement discussions, payer conversations, and clinician adoption. Engage with frontline clinicians early in the design and deployment process to refine human factors and minimize training burdens. Finally, evaluate business models that combine hardware, consumables, and services into subscription or managed-service offerings that align incentives across manufacturers, providers, and payers. By focusing on these priority actions, leaders can strengthen resilience, improve clinical value, and capture new revenue streams as care delivery continues to evolve.

A transparent description of the multi-method research approach combining primary interviews, documentation review, and expert validation to ensure robust and actionable insights

The research underpinning this executive summary combines primary interviews, secondary literature analysis, device documentation review, and cross-functional expert validation to ensure a comprehensive and balanced perspective. Primary input was obtained through structured interviews with clinicians, biomedical engineers, procurement leaders, and industry executives to capture practical implementation challenges and real-world performance considerations. Secondary analysis included regulatory filings, product manuals, and peer-reviewed clinical studies to corroborate claims about safety, usability, and technological features.

Where possible, device specifications and post-market notices were reviewed to assess maintenance requirements, software update pathways, and interoperability claims. The research team triangulated findings across sources and used subject-matter workshops to test hypotheses about adoption drivers and competitive positioning. Limitations include the rapid pace of technological change and potential variability in local regulatory interpretations; therefore, findings emphasize durable trends and qualitative insights rather than short-term fluctuations. Transparency in method and an emphasis on cross-validation provide confidence that the conclusions and recommendations are practical and relevant for decision-makers engaged in procurement, clinical integration, or strategic planning.

A conclusive synthesis reinforcing how interoperability, services, and resilience combine to drive clinical value and commercial success across infusion pump ecosystems

In conclusion, infusion pumps and accessories are central to contemporary efforts to improve medication safety, enable home-based care, and integrate therapeutic delivery with digital health platforms. The sector is shifting from standalone devices to services-oriented solutions that bundle hardware, software, and ongoing support, a trend that rewards companies capable of delivering seamless interoperability, demonstrable clinical value, and reliable service networks. Tariff dynamics and supply chain pressures in recent policy cycles have reinforced the need for diversified sourcing and operational resilience, while regional differences in regulation and care delivery require adaptive commercialization strategies.

To translate these macro trends into operational success, stakeholders must prioritize interoperability, invest in real-world evidence generation, and structure service offerings that reduce clinician workload and enhance patient adherence. By doing so, manufacturers and providers can both improve clinical outcomes and create sustainable business models that respond to evolving payer and regulatory expectations. The insights presented here are intended to support informed decision-making across product development, procurement, and clinical adoption, helping organizations to navigate complexity and to seize opportunities in a rapidly changing landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Infusion Pumps & Accessories Market, by Product

  • 8.1. Accessories & Consumables
  • 8.2. Infusion Pumps
    • 8.2.1. Ambulatory Infusion Pumps
    • 8.2.2. Enteral Feeding Pumps
    • 8.2.3. Implantable Infusion Pumps
    • 8.2.4. Insulin Infusion Pumps
    • 8.2.5. Patient-Controlled Analgesia Pumps
    • 8.2.6. Syringe Infusion Pumps
    • 8.2.7. Volumetric Infusion Pumps

9. Infusion Pumps & Accessories Market, by Operation

  • 9.1. Electrically Operated
  • 9.2. Mechanically Operated

10. Infusion Pumps & Accessories Market, by Application

  • 10.1. Diabetes Management
  • 10.2. Gastroenterology
  • 10.3. Hematology
  • 10.4. Neurology
  • 10.5. Oncology
  • 10.6. Pain Management

11. Infusion Pumps & Accessories Market, by End-User

  • 11.1. Academic & Research Institutes
  • 11.2. Ambulatory Care Settings
  • 11.3. Home Care
  • 11.4. Hospitals & Clinics

12. Infusion Pumps & Accessories Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Infusion Pumps & Accessories Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Infusion Pumps & Accessories Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Infusion Pumps & Accessories Market

16. China Infusion Pumps & Accessories Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Avanos Medical, Inc.
  • 17.6. B. Braun SE
  • 17.7. Baxter International, Inc.
  • 17.8. Bayer AG
  • 17.9. Becton, Dickinson, and Company
  • 17.10. Boston Scientific Corporation
  • 17.11. Cane S.p.A.
  • 17.12. Chemyx Inc.
  • 17.13. Eitan Medical
  • 17.14. Epic Medical Pty Ltd.
  • 17.15. F. Hoffmann-La Roche AG
  • 17.16. Fresenius SE & Co. KGaA
  • 17.17. Freudenberg Group
  • 17.18. FUJIFILM Corporation
  • 17.19. ICU Medical, Inc.
  • 17.20. IRadimed Corporation
  • 17.21. Medtronic plc
  • 17.22. Micrel Medical Devices SA
  • 17.23. Moog Inc.
  • 17.24. Narang Medical Limited
  • 17.25. Nipro Corporation
  • 17.26. Omnipod by Insulet Corporation
  • 17.27. SAI Infusion Technologies
  • 17.28. Shenzhen Hawk Medical Instrument Co., Ltd
  • 17.29. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 17.30. Tandem Diabetes Care, Inc.
  • 17.31. Teleflex Incorporated
  • 17.32. TERUMO CORPORATION
  • 17.33. Thermo Fisher Scientific Inc.
  • 17.34. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ENTERAL FEEDING PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ENTERAL FEEDING PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ENTERAL FEEDING PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INSULIN INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INSULIN INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INSULIN INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ELECTRICALLY OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ELECTRICALLY OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ELECTRICALLY OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY MECHANICALLY OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY MECHANICALLY OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY MECHANICALLY OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 126. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 128. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 129. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 130. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 144. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 146. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 147. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 148. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 150. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 152. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 153. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 154. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)